BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17889169)

  • 1. Contribution of marginal donors to liver transplantation for hepatitis C virus infection.
    Briceño J; Ciria R; Pleguezuelo M; Naranjo A; Sánchez-Hidalgo J; Ruiz-Rabelo J; López-Cillero P; Luque A; de la Mata M; Rufián S
    Transplant Proc; 2007 Sep; 39(7):2297-9. PubMed ID: 17889169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marginal donors in liver transplantation.
    Tisone G; Manzia TM; Zazza S; De Liguori Carino N; Ciceroni C; De Luca I; Toti L; Casciani CU
    Transplant Proc; 2004 Apr; 36(3):525-6. PubMed ID: 15110580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.
    Boin IF; Ataide EC; Leonardi MI; Stucchi R; Sevá-Pereira T; Pereira IW; Cardoso AR; Caruy CA; Luzo A; Leonardi LS
    Transplant Proc; 2008 Apr; 40(3):792-6. PubMed ID: 18455019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the use of marginal liver donors change recipient survival rate?
    Rocha MB; Boin IF; Escanhoela CA; Leonardi LS
    Transplant Proc; 2004 May; 36(4):914-5. PubMed ID: 15194314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
    Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients.
    Pérez-Daga JA; Ramírez-Plaza C; Suárez MA; Santoyo J; Fernández-Aguilar JL; Aranda JM; Sánchez-Pérez B; González-Sánchez A; Alvárez A; Valle M; Bondía JA
    Transplant Proc; 2008 Nov; 40(9):2959-61. PubMed ID: 19010159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation from old donors into HCV and non-HCV recipients.
    Baccarani U; Adani GL; Toniutto P; Sainz M; Lorenzin D; Viale PL; Ramacciato G; Risaliti A; Bresadola F
    Transplant Proc; 2004 Apr; 36(3):527-8. PubMed ID: 15110581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of clinical variables of donors and recipients with respect to short-term graft outcome in human liver transplantation.
    Totsuka E; Fung U; Hakamada K; Tanaka M; Takahashi K; Nakai M; Morohashi S; Nishimura A; Ishizawa Y; Ono H; Toyoki Y; Narumi S; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2215-8. PubMed ID: 15561195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
    Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
    Doyle MB; Anderson CD; Vachharajani N; Lowell JA; Shenoy S; Lisker-Melman M; Korenblat K; Crippin JS; Chapman WC
    Arch Surg; 2008 Jul; 143(7):679-85; discussion 685. PubMed ID: 18645111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
    Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR; Pokorny H; Hetz H; Herkner H; Rasoul-Rockenschaub S; Soliman T; Wekerle T; Berlakovich GA; Steininger R; Muehlbacher F
    Transplantation; 2007 Mar; 83(5):588-92. PubMed ID: 17353779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience.
    Ricchiuti A; Brunati A; Mirabella S; Pierini A; Franchello A; Salizzoni M
    Transplant Proc; 2005; 37(6):2569-70. PubMed ID: 16182746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival.
    Reese PP; Sonawane SB; Thomasson A; Yeh H; Markmann JF
    Transplantation; 2008 Jun; 85(12):1737-44. PubMed ID: 18580465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.